ZA92142B - Substituted alkenoic acid and its derivatives - Google Patents

Substituted alkenoic acid and its derivatives

Info

Publication number
ZA92142B
ZA92142B ZA92142A ZA92142A ZA92142B ZA 92142 B ZA92142 B ZA 92142B ZA 92142 A ZA92142 A ZA 92142A ZA 92142 A ZA92142 A ZA 92142A ZA 92142 B ZA92142 B ZA 92142B
Authority
ZA
South Africa
Prior art keywords
derivatives
alkenoic acid
substituted alkenoic
acid
carboxyphenylthio
Prior art date
Application number
ZA92142A
Other languages
English (en)
Inventor
Heinrich Meier
Meier Heinrich
John E Butler
E Butler John
Trevor Smyth Abram
Smyth Abram Trevor
Peter Norman
Norman Peter
Stephen Richard Tudhope
Richard Tudhope Stephen
Phillip John Gardiner
John Gardiner Phillip
Nigel James Cuthberg
James Cuthberg Nigel
Hilary Patricia Francis
Patricia Francis Hilary
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA92142B publication Critical patent/ZA92142B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
ZA92142A 1991-01-10 1992-01-09 Substituted alkenoic acid and its derivatives ZA92142B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919100493A GB9100493D0 (en) 1991-01-10 1991-01-10 Substituted alkenoic acid and its derivatives

Publications (1)

Publication Number Publication Date
ZA92142B true ZA92142B (en) 1992-09-30

Family

ID=10688219

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92142A ZA92142B (en) 1991-01-10 1992-01-09 Substituted alkenoic acid and its derivatives

Country Status (21)

Country Link
US (1) US5246966A (pl)
EP (1) EP0494621B1 (pl)
JP (1) JPH04321663A (pl)
KR (1) KR920014775A (pl)
AT (1) ATE125793T1 (pl)
AU (1) AU643355B2 (pl)
CA (1) CA2058884A1 (pl)
CZ (1) CZ286679B6 (pl)
DE (1) DE69203732T2 (pl)
DK (1) DK0494621T3 (pl)
ES (1) ES2076559T3 (pl)
FI (1) FI920075A (pl)
GB (1) GB9100493D0 (pl)
GR (1) GR3017031T3 (pl)
HU (2) HU213475B (pl)
IE (1) IE920073A1 (pl)
IL (1) IL100599A (pl)
MY (1) MY108136A (pl)
PL (2) PL169083B1 (pl)
RU (1) RU2058979C1 (pl)
ZA (1) ZA92142B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523946D0 (en) * 1995-11-23 1996-01-24 Bayer Ag Leukotriene antagonistic benzoic acid derivatives
DE19943634A1 (de) * 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943636A1 (de) * 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530222D0 (en) * 1985-12-07 1986-01-15 Lilly Industries Ltd Organic compounds
GB2218416A (en) * 1988-05-13 1989-11-15 Bayer Ag Leukotriene disease antagonists
EP0410241B1 (en) * 1989-07-27 1993-10-20 Bayer Ag Aryl alkenoic acid derivatives as leukotriene antagonists

Also Published As

Publication number Publication date
EP0494621A1 (en) 1992-07-15
MY108136A (en) 1996-08-15
IE920073A1 (en) 1992-07-15
ES2076559T3 (es) 1995-11-01
CZ286679B6 (cs) 2000-06-14
IL100599A (en) 1997-02-18
CS7492A3 (en) 1992-08-12
DE69203732D1 (de) 1995-09-07
ATE125793T1 (de) 1995-08-15
US5246966A (en) 1993-09-21
HU211553A9 (en) 1995-12-28
RU2058979C1 (ru) 1996-04-27
DE69203732T2 (de) 1996-01-18
IL100599A0 (en) 1992-09-06
CA2058884A1 (en) 1992-07-11
HUT60469A (en) 1992-09-28
HU9200090D0 (en) 1992-03-30
EP0494621B1 (en) 1995-08-02
AU643355B2 (en) 1993-11-11
GR3017031T3 (en) 1995-11-30
DK0494621T3 (da) 1995-12-27
HU213475B (en) 1997-06-30
PL169083B1 (pl) 1996-05-31
JPH04321663A (ja) 1992-11-11
AU1012292A (en) 1992-07-16
KR920014775A (ko) 1992-08-25
FI920075A (fi) 1992-07-11
GB9100493D0 (en) 1991-02-20
PL293117A1 (en) 1992-12-28
FI920075A0 (fi) 1992-01-08
PL168848B1 (pl) 1996-04-30

Similar Documents

Publication Publication Date Title
DE69108138D1 (de) Imidazopyridinderivate und ihre Verwendung.
HK55797A (en) Fluoro substituted benzocycloheptapyridine compounds compositions and methods of use as antihistaminic compounds
YU68792A (sh) Postupak za dobivanje derivata bakatina iii i 10-dezacetil-bakatina iii
ATE98227T1 (de) Di-tert-butyl-hydroxyphenylthioderivate, deren herstellung und verwendung.
ATE49211T1 (de) Dreizyklische oxindole als antientzuendungsmittel.
DE69514284D1 (de) Herstellung von Catechol-Estrogen-Derivaten
GR3017031T3 (en) Substituted alkenoic acid and its derivatives.
ATE98239T1 (de) 2,5,6,7-tetranor-4,8-inter-m-phenylen-pgi2derivate.
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
DE68909025D1 (de) Mittel zur Verhinderung von Zahnbelagbildung.
PL297368A1 (en) Novel derivatives of 2h-benzo (b) pyrane substituted with aryl or n-heteroaryl at position 4, method of obtaining them and their applications as well as preparation containing these compounds
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
IT8821138A0 (it) Sali di (r,s) 3 (4 fenil 1piperazinil) 1,2 propandiolo.
EP0407877A3 (en) 1,2-dihaloazolylethane derivatives and fungicides containing them
SU1783778A1 (ru) Производные 4-(1-окси-1-аминокарбонил-2,2,2-трифторэтил)-n-этиланилинов, обладающие антидотной активностью к хлорсульфурону